For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
6
views
0
references
 Top references
cited by
3
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      3,381
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Risks of troglitazone apparent before approval in USA.

      Author(s):
      Publication date:
      Journal: Diabetologia
      Keywords: Chromans, adverse effects, standards, Diabetes Mellitus, Type 2, drug therapy, Humans, Hypoglycemic Agents, Risk Assessment, Thiazolidinediones

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 16601971
          DOI:: 10.1007/s00125-006-0245-0

          ScienceOpen disciplines: Chemistry
          Keywords: Chromans,adverse effects,standards,Diabetes Mellitus, Type 2,drug therapy,Humans,Hypoglycemic Agents,Risk Assessment,Thiazolidinediones
          Data availability:
          ScienceOpen disciplines: Chemistry
          Keywords: Chromans, adverse effects, standards, Diabetes Mellitus, Type 2, drug therapy, Humans, Hypoglycemic Agents, Risk Assessment, Thiazolidinediones

          Comments

          Comment on this article

          scite_

          Similar content3,381

          See all similar

          Cited by3

          See all cited by